Difference between revisions of "Team:MIT"

Line 37: Line 37:
 
     </a>
 
     </a>
 
   </li>
 
   </li>
−
</ul>
+
<br></ul><br>
 +
<center><h2>We've accomplished a lot in successfully creating new, hormone-inducible mammalian promoters, characterizing a miRNA sensing platform in TERT-immortalized human endometrial stromal cells (tHESC) culture under varying estrogen conditions, and testing the functionality of a serine integrase (TP901) in a mammalian line as a biological latch, and we've spent a long time visualizing how these tools could be used in the long term to help patients with endometriosis.</h2></center>
 +
<ul class="img-home">
 +
<li> 
 +
    <a href="https://2016.igem.org/Team:MIT/future">
 +
      <img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" >
 +
      <span class="text-content"><span><br>We worked with experts in endometriosis to lay out a basic clinical plan, designed a possible full circuit using our synthetic biological parts, and collaborated with the BU Hardware team to test and confirm that mammalian cells can grow in a microfluidics device.<br><br><br><br><br>Read more about the future applications of our work</span></span>
 +
    </a>
 +
  </li>
  
 
<div class="column full_size" >
 
<div class="column full_size" >

Revision as of 20:05, 16 October 2016


This diagnostic process can be expedited by using the following synthetic biological tools to sense molecular markers in endometrial biopsy samples.



We've accomplished a lot in successfully creating new, hormone-inducible mammalian promoters, characterizing a miRNA sensing platform in TERT-immortalized human endometrial stromal cells (tHESC) culture under varying estrogen conditions, and testing the functionality of a serine integrase (TP901) in a mammalian line as a biological latch, and we've spent a long time visualizing how these tools could be used in the long term to help patients with endometriosis.